Inactive Instrument

Avivagen Inc. Stock Toronto S.E.

VIV.H

CA05382F2026

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that enhances feed intake and supports immune function, thereby supporting general health and performance. The Companyâ€™s operations as one segment, products based on OxC-beta Technology. Its OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia.

Employees

Sector

Fishing & Farming

More about the company

Google lets you customize your preferred sources.

Choose MarketScreener

Market Cap	591K 517K 477K 441K 837K 56.41M 851K 5.71M 2.24M 27.7M 2.22M 2.17M 95.94M	P/E 2021	-3.05x	P/E 2022	-1.52x
Enterprise Value	6.39M 5.59M 5.15M 4.77M 9.05M 610M 9.2M 61.7M 24.19M 299M 23.97M 23.46M 1.04B	EV / Sales 2021	20.5x	EV / Sales 2022	17.7x
Free-Float	98.89%	Yield 2021 *	-	Yield 2022	-

24-04-24	Avivagen Makes Voluntary Assignment into Bankruptcy Under the BIA	NE
21-04-06	Avivagen Discusses Significant Purchase Orders for OxC-beta(TM) Livestock with The Stock Day Podcast	NE
20-07-23	Avivagen: The OxC-beta(TM) Technology Is A True Game Changer	NE
19-10-02	Avivagen Inc. CEO, Kym Anthony, Joins The Stock Day Podcast to Discuss Their Expansion Strategy	NE
18-05-01	Avivagen Announces its Attendance at the Bloom Burton & Co. Healthcare Investor Conference	GL

Manager	Title	Age	Since
G. Anthony CEO	Chief Executive Officer	70	2017-02-08
Ira Levy DFI	Director of Finance/CFO	-	-
Drew Basek IRC	Investor Relations Contact	-	2017-02-28

Director	Title	Age	Since
David Hankinson CHM	Chairman	-	2005-08-03
G. Anthony CHM	Chairman	70	2014-07-24
Paul Mesburis BRD	Director/Board Member	56	2016-04-04

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AVIVAGEN INC.	-.--%	-.--%	-	-	77
GUANGDONG HAID GROUP CO., LIMITED	-2.19%	-2.90%	-22.03%	-5.35%	10.71B
NEW HOPE LIUHE CO.,LTD.	-0.14%	+2.92%	-26.61%	-40.62%	4.65B
PT CHAROEN POKPHAND INDONESIA TBK	+0.33%	-1.29%	-36.83%	-42.88%	2.78B
AKTIESELSKABET SCHOUW & CO.	-0.56%	+1.65%	-0.80%	+13.21%	2.15B
BEIJING DABEINONG TECHNOLOGY GROUP CO.,LTD.	+0.69%	+0.34%	-28.88%	-57.84%	1.85B
AVANTI FEEDS LIMITED	+0.47%	-3.21%	+24.22%	+130.27%	1.31B
FUJIAN AONONG BIOLOGICAL TECHNOLOGY GROUP INCORPORATION LIMITED	0.00%	-3.07%	-21.55%	-69.69%	1.14B
FUJIAN TIANMA SCIENCE AND TECHNOLOGY GROUP CO., LTD	+3.98%	-4.51%	-6.40%	-7.02%	915M
WELLHOPE FOODS CO., LTD.	-1.42%	+0.81%	-27.41%	-32.72%	792M
Average	+0.12%	-0.36%	-16.25%	-12.52%	2.92B
Weighted average by Cap.	-0.76%	-0.10%	-20.44%	-14.62%

Avivagen Inc. Stock Toronto S.E.

Stocks

VIV.H

CA05382F2026

Fishing & Farming

Valuation: Avivagen Inc.

Press Releases: Avivagen Inc.

Managers and Directors: Avivagen Inc.

Animal Feed

Financials

Company Profile

	2021	2022
Net sales	1.3M 1.13M 1.05M 967K 1.84M 124M 1.87M 12.52M 4.91M 60.75M 4.87M 4.76M 210M	939K 822K 758K 701K 1.33M 89.65M 1.35M 9.07M 3.56M 44.02M 3.53M 3.45M 152M
Net income	-6.39M -5.59M -5.16M -4.77M -9.06M -610M -9.21M -61.77M -24.22M -300M -24M -23.49M -1.04B	-6.07M -5.31M -4.89M -4.53M -8.59M -579M -8.74M -58.61M -22.97M -284M -22.77M -22.28M -985M
Net Debt	5.4M 4.72M 4.36M 4.03M 7.65M 515M 7.78M 52.15M 20.44M 253M 20.27M 19.83M 877M	5.8M 5.07M 4.68M 4.33M 8.21M 553M 8.35M 55.99M 21.95M 272M 21.76M 21.29M 941M